Article By:
Zacks Investment Research
Thursday, April 27, 2023 6:50 AM EDT
Merck came out with quarterly earnings of $1.40 per share.
In this article: MRK
OncoSec Raising Its Profile In Fight Against Cancer
I appreciate a promising investment that also helps people. Bullish on $ONCS and $MRK.
OncoSec Raising Its Profile In Fight Against Cancer
Thanks for this info, @[Terry Chrisomalis](user:5023). Is there any sort of official partnership or cooperation between #OncoSecMedical and #Merck to use ImmunoPulse IL-12 technology in conjunction with #Keytruda? $ONCS $MRK
OncoSec Raising Its Profile In Fight Against Cancer
Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY